PCAOB Report Signals Relief for US-Listed Chinese Biotechs
A report issued last week by the US Public Company Accounting Oversight Board (PCAOB) indicated...
Policy / Regulatory
WuXi Biologics’ Shanghai Subsidiary Removed from US UVL
China-based Contract Research, Development and Manufacturing Organization (CRDMO) WuXi Biologics (HKG: 2269) announced that its...
Liaoning Publishes Fourth Round of Volume-Based Procurement Winning Bids
The Liaoning drug and medical consumables centralized procurement website has published the fourth round of...
China’s COVID-19 Vaccination Second Booster Shot Plan Released
The National Health Commission website indicates that the COVID-19 Joint Prevention and Control Mechanism of...
Beijing Releases COVID-19 Infection Drug List to Address Stocking Issues
The Beijing Municipal Health Commission formulated and released the “COVID-19 infection drug list” (first edition),...
China’s State Council Boosts Internet Medical Services Amid COVID-19
The State Council released a notification in relation to the COVID-19 pandemic, seeking to ramp...
Northeast Pharmaceutical Fined RMB 133M for Monopoly Selling
Northeast Pharmaceutical Co., Ltd (SHE: 000597) was fined RMB 133 million (USD 19m) by the...
NMPA Extends Validation Period for COVID-19 Antigen Detection Reagents
The National Medical Products Administration released a notification extending the validation period of approvals for...
24 Provinces Form Alliances for Volume-Based Procurement of Medical Consumables
The Henan provincial alliance procurement office released a notification indicating that 24 provinces/regions will form...
NHSA Delays NRDL Negotiations Due to COVID-19 Disruptions
The National Healthcare Security Administration (NHSA) announced that it has been decided to delay the...
Hainan’s New Regulations on Medical Devices in Boao Lecheng to Take Effect in 2023
The “Regulations on the Administration of Medical Devices in Boao Lecheng International Medical Tourism Pilot...
China’s NMPA Issues New GSP Appendix for Drug Retailing Quality Management
China’s National Medical Products Administration (NMPA) has released “Good Supply Practice (GSP) Appendix 6: Quality...
China’s NMPA Seeks Feedback on Drug Quality Management Provisions
China’s National Medical Products Administration (NMPA) has released a draft proposal titled “Provisions on the...
China’s NMPA Shifts to Electronic Drug Filings from January 2023
China’s National Medical Products Administration (NMPA) has released a notification indicating the initiation of electronic...
China’s Drug-Eluting Stent Procurement Results Announced
The national high-value medical consumables alliance procurement office has released the results of the successive...
NMPA Launches Electronic Certificates for API and Pharmaceutical Product Exports
The National Medical Products Administration (NMPA) has released a notification regarding the initiation of two...
China’s Medical Product Trade Surplus Declines Amid COVID-19 Impact
The China Chamber of Commerce for Import and Export of Medicines and Health Products (CCCMHPIE)...
Tianjin Tianyao Fined for Anti-Monopoly Violations in Carmustine Sales
China-based Tianjin Tianyao Pharmaceutical Co., Ltd (SHA: 600488) has been fined RMB 27.72 million (USD...
China Releases Third Batch of VAT Discounts for Anti-Tumor and Rare Disease Drugs
The Ministry of Finance, General Administration of Customs, State Taxation Administration, and National Medical Products...
Shanghai Hosts Yangtze River Delta Alliance VBP Tender for 44 Drugs
Shanghai’s Sunshine Medical Procurement All-in-One (SMPA) has released a document indicating that the city will...